Literature DB >> 893679

Evidence for cardiomyopathy in familial diabetes mellitus.

T J Regan, M M Lyons, S S Ahmed, G E Levinson, H A Oldewurtel, M R Ahmad, B Haider.   

Abstract

Recent epidemiologic studies have suggested that cardiac disease in common in diabetics and may often have a noncoronary basis. To examine the status of the left ventricle, 17 adult-onset diabetics of familial type without hypertension or obesity underwent hemodynamic study and were compared to 9 controls of similar age. Of the 17, 12 subjects had no significant occlusive lesions by coronary angiography. From this group eight without heart failure had a modest, but significant, elevation of left ventricular end-diastolic pressure. End-diastolic and stroke volumes were reduced, but ejection fraction and mean rate of fiber shortening were within normal limits. The left ventricular end-diastolic pressure/volume ratio was significantly higher than controls. Afterload increments effected a significant increase of filling pressure compared to normals without a stroke volume response, consistent with a preclinical cardiomyopathy. Four patients with prior heart failure had similar but more extensive abnormalities. None had local dyskinesia by angiography, and lactate production was not observed during pacing-induced tachycardia. Left ventricular biopsy in two patients without ventricular decompensation showed interstitial collagen deposition with relatively normal muscle cells. These findings suggest a myopathic process without ischemia. Postmortem studies were performed in 11 uncomplicated diabetics. Nine were without significant obstructive disease of the proximal coronary arteries, and the majority succumbed with cardiac failure. On left ventricular sections, none had evident luminal narrowing of the intramural vessels. All nine exhibited periodic acid-Schiff-positive material in the interstitium. Collagen accumulation was present in perivascular loci, between myofibers, or as replacement fibrosis. Multiple samples of left ventricle and septum revealed enhanced triglyceride and cholesterol concentrations, as compared to controls. Thus, a diffuse extravascular abnormality may be a basis for cardiomyopathic features in diabetes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893679      PMCID: PMC372437          DOI: 10.1172/JCI108843

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  AUTOMATED DETERMINATION OF SERUM TOTAL CHOLESTEROL.

Authors:  J B LEVINE; B ZAK
Journal:  Clin Chim Acta       Date:  1964-10       Impact factor: 3.786

2.  THE STUDY OF LEFT VENTRICULAR FUNCTION IN MAN BY INCREASING RESISTANCE TO VENTRICULAR EJECTION WITH ANGIOTENSIN.

Authors:  J ROSS; E BRAUNWALD
Journal:  Circulation       Date:  1964-05       Impact factor: 29.690

3.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

4.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

5.  Cine coronary arteriography.

Authors:  F M SONES; E K SHIREY
Journal:  Mod Concepts Cardiovasc Dis       Date:  1962-07

6.  The relation between myocardial lesions and coronary artery disease. I. An unselected necropsy study.

Authors:  C J SCHWARTZ; J R MITCHELL
Journal:  Br Heart J       Date:  1962-11

7.  Determination of intermediary metabolites by enzymic fluorimetry.

Authors:  P GREENGARD
Journal:  Nature       Date:  1956-09-22       Impact factor: 49.962

8.  The dye dilution method for describing the central circulation. An analysis of factors shaping the time-concentration curves.

Authors:  E V NEWMAN; M MERRELL; A GENECIN; C MONGE; W R MILNOR; W P McKEEVER
Journal:  Circulation       Date:  1951-11       Impact factor: 29.690

9.  Effects of bed rest on cardiovascular function and work performance.

Authors:  H L TAYLOR; A HENSCHEL
Journal:  J Appl Physiol       Date:  1949-11       Impact factor: 3.531

10.  Changes in the coronary vasculature in endomyocardial fibrosis and their possible significance.

Authors:  Z A Andrade; A R Teixeira
Journal:  Am Heart J       Date:  1973-08       Impact factor: 4.749

View more
  148 in total

1.  Serial changes in the myocardial beta-adrenergic signalling system in two models of non-insulin dependent diabetes mellitus.

Authors:  B Huisamen; E Marais; S Genade; A Lochner
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

Review 2.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.

Authors:  Guanghong Jia; Adam Whaley-Connell; James R Sowers
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 3.  Type 2 diabetes mellitus and cardiovascular exercise performance.

Authors:  Judith G Regensteiner
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

4.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy.

Authors:  H Wakasaki; D Koya; F J Schoen; M R Jirousek; D K Ways; B D Hoit; R A Walsh; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.

Authors:  Cheng-Yang Wu; Santhosh Satapati; Wenjun Gui; R Max Wynn; Gaurav Sharma; Mingliang Lou; Xiangbing Qi; Shawn C Burgess; Craig Malloy; Chalermchai Khemtong; A Dean Sherry; David T Chuang; Matthew E Merritt
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

6.  Resting parasympathetic status and cardiovascular response to orthostatic and behavioral challenges in type I insulin-dependent diabetes mellitus.

Authors:  B E Hurwitz; R E Quillian; J B Marks; N Schneiderman; R F Agramonte; C R Freeman; A M La Greca; J S Skyler
Journal:  Int J Behav Med       Date:  1994

Review 7.  Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.

Authors:  Jennifer G Duncan
Journal:  Pediatr Cardiol       Date:  2011-02-02       Impact factor: 1.655

Review 8.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.

Authors:  M Sulaiman; M J Matta; N R Sunderesan; M P Gupta; M Periasamy; M Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

Review 10.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.